We are live on
!
Find out more
MC
Martin & Co Portfolio holdings
AUM
$587M
1-Year Est. Return
16.39%
This Fund
S&P 500
This Quarter
Est. Return
-12.74%
1 Year Est. Return
+16.39%
3 Year Est. Return
+57.15%
5 Year Est. Return
+65.41%
10 Year Est. Return
+254.67%
AUM
$350M
AUM Growth
-$41.6M
(-11%)
Cap. Flow
+$12.8M
Cap. Flow
% of AUM
3.65%
Top 10 Holdings %
Top 10 Hldgs %
29.4%
Holding
108
New
–
Increased
99
Reduced
7
Closed
1
Top Buys
| 1 |
Warner Bros
WBD
|
+$2.48M |
| 2 |
SKX
Skechers
SKX
|
+$1.05M |
| 3 |
Omnicell
OMCL
|
+$1.01M |
| 4 |
John B. Sanfilippo & Son
JBSS
|
+$944K |
| 5 |
LGTY
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
|
+$934K |
Top Sells
| 1 |
CERN
Cerner Corp
CERN
|
+$6M |
| 2 |
Transcat
TRNS
|
+$149K |
| 3 |
RTX Corp
RTX
|
+$6.34K |
| 4 |
3M
MMM
|
+$5.8K |
| 5 |
Citigroup
C
|
+$5.45K |
Sector Composition
| 1 | Technology | 14.23% |
| 2 | Healthcare | 11.28% |
| 3 | Financials | 10.18% |
| 4 | Consumer Staples | 6.84% |
| 5 | Industrials | 6.37% |
Similar funds
PFG
FMI
DP
BMWS
BCM
PFG
EGWAG
GIM
Martin & Co's Q2 2022 Portfolio in Review
As of Q2 2022, Martin & Co held 108 positions worth $350M, down 11% from $392M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Martin & Co deployed $12.8M of net new capital in Q2 2022, adding to 99 existing holdings.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Transcat, an estimated $149K trimmed.
- Martin & Co added most to Warner Bros in Q2 2022, an estimated $2.48M increase.
- Martin & Co's biggest Q2 2022 reduction was Transcat, cutting an estimated $149K.
- Martin & Co fully exited Cerner Corp in Q2 2022, selling an estimated $6M.
- Martin & Co's ten largest holdings make up 29% of its $350M portfolio in Q2 2022.
- Martin & Co opened 0 new positions and closed 1 in Q2 2022.
- Martin & Co's portfolio value fell 11% quarter-over-quarter to $350M.
Based on Martin & Co's 13F filing for Q2 2022, filed 11 Aug 2022.